Cronos Group reported a 30% year-over-year increase in net revenue, reaching $25.3 million in Q1 2024. This growth was primarily driven by strong performances in Canada and Israel. The company maintains a strong balance sheet with $855 million in cash and cash equivalents.
Net revenue increased by 30% year-over-year to $25.3 million.
Canada experienced a 31% year-over-year revenue growth.
Israel saw a 27% year-over-year revenue growth.
Spinach® brand continues to gain recognition holding a 14.4% market share in Q1 2024 in the edibles category.
The Company reiterates its previously announced operating expense savings target of $5 to $10 million in 2024 primarily driven by savings in general and administrative, and research and development. Cronos anticipates that the net change in cash, defined as the sum of cash and cash equivalents and short-term investments will be positive in 2024.